Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Cardiology
•
Cardiovascular Imaging
When measuring LV volumes on Echo using ultrasound enhancing agents, are you using different volume cut offs?
If so, is there a good reference paper?
Related Questions
Is there evidence to support the use of automated blood pressure checks during exercise stress testing, or does manual BP remain superior in terms of accuracy and consistency?
Do you prefer CTA or MRA for further imaging in patients with ascending aortic dilatation detected on TTE?
What is the clinical significance of intracardiac vacuum(s) noted during diastole, especially in terms of the diagnosis and management of diastolic dysfunction?
Would you favor CT AV calcium score or dobutamine stress echo for a patient with symptomatic AS and aortic valve with normal SV/SV index, Vmax 3.4m/s, AVA < 1.0cm2 and mean gradient < 40mmHg?
Should there be age cut-off considerations when ordering TTEs with bubble routinely as part of stroke work-up?
What is a reasonable stepwise approach to diagnostic imaging when there is ongoing concern for cardiac amyloidosis?
How do you use coronary CTA qualitative plaque analysis (low attenuation versus calcified plaque, for example) in routine clinical practice?
How long do you recommend waiting after variceal bleeding and banding before a transesophageal echocardiogram can be performed safely?
What stress testing modality do you choose to evaluate patients who are unable to exercise and have anomalous coronary arteries?
Do you prefer TTE, CMR, or cardiac CT for the evaluation of PFOs?